BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/20/2017 4:03:35 AM | Browse: 1368 | Download: 2408
 |
Received |
|
2017-06-30 00:33 |
 |
Peer-Review Started |
|
2017-06-30 08:33 |
 |
First Decision by Editorial Office Director |
|
2017-08-15 02:38 |
 |
Return for Revision |
|
2017-08-16 09:16 |
 |
Revised |
|
2017-09-13 14:34 |
 |
Publication Fee Transferred |
|
2017-09-27 09:06 |
 |
Second Decision by Editor |
|
2017-09-25 06:37 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2017-09-26 01:48 |
 |
Articles in Press |
|
2017-09-26 01:48 |
 |
Edit the Manuscript by Language Editor |
|
2017-11-01 02:53 |
 |
Typeset the Manuscript |
|
2017-11-16 01:04 |
 |
Publish the Manuscript Online |
|
2017-11-20 04:03 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shan Xing, Xin Zheng, Tao Zeng, Mu-Sheng Zeng, Qian Zhong, Yue-Song Cao, Kai-Lu Pan, Chu Wei, Fan Hou and Wan-Li Liu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wan-Li Liu, PhD, Professor, Research Scientist, Department of Clinical Laboratory, Sun Yat-sen University Cancer Center, 651 Dongfeng Road East, Guangzhou 510060, Guangdong Province, China. liuwl@sysucc.org.cn |
| Key Words |
Esophageal squamous cell carcinoma; Prognostic biomarker; Chitinase 3-like 1; Macrophage; Esophageal squamous cell carcinoma |
| Core Tip |
The current staging system is inadequate for predicting post-treated survival. Our study first established a connection between pretreated chitinase 3-like 1 (CHI3L1) and patients with esophageal squamous cell carcinoma (ESCC), and serum CHI3L1 was primarily secreted by ESCC-surrounded macrophages, suggesting that CHI3L1 was a simple and inexpensive prognostic factor. This simple, convenient serological testing allows for clinical application. In addition, in our study, the ESCC microenvironment, especially the secretion of IL - 6 by esophageal tumor cells, promotes the macrophage production of CHI3L1. These findings might help to identify high-risk patients for treatment decisions and to elucidate the mechanisms of ESCC. |
| Publish Date |
2017-11-20 04:03 |
| Citation |
Xing S, Zheng X, Zeng T, Zeng MS, Zhong Q, Cao YS, Pan KL, Wei C, Hou F, Liu WL. Chitinase 3-like 1 secreted by peritumoral macrophages in esophageal squamous cell carcinoma is a favorable prognostic factor for survival. World J Gastroenterol 2017; 23(43): 7693-7704 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i43/7693.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i43.7693 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.